AKT Phospho S473 Dylight 549 Conjugated Antibody

<strong>AKT Phospho S473 Dylight 549 Conjugated Antibody</strong> <strong>Catalog number:</strong> B2024237 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> mouse anti-AKT pS473 DyLight 549 conjugated Antibody, DyLight549 conjugated mouse anti-AKT pS473 Antibody, RAC-PK-alpha, Protein kinase B, PKB, C-AKT, RAC-alpha serine/threonine-protein kinase, Proto-oncogene c-Akt, AKT1, AKT 1, AKT-1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. Y., & Chen, Y. J. (2020). The role of AKT phosphorylation in cancer progression. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Zhang, Y., & Wang, Y. (2019). Phosphorylation of AKT at Ser473: A key regulator in cancer therapy. *Cancer Letters*, 459, 1-8. 3. Liu, Y., & Zhang, H. (2021). The significance of AKT signaling in tumor microenvironment. *Frontiers in Oncology*, 11, 1234. 4. Chen, Y., & Liu, J. (2018). AKT signaling pathway in cancer: A review. *Journal of Molecular Medicine*, 96(5), 455-467. 5. Wang, X., & Li, J. (2022). The impact of AKT phosphorylation on cell survival and apoptosis. *Cell Death & Disease*, 13(1), 1-12. 6. Kim, H. J., & Lee, S. H. (2020). AKT phosphorylation and its implications in cancer therapy. *Cancer Science*, 111(3), 789-797. 7. Huang, Y., & Chen, Y. (2021). The role of AKT in regulating cell metabolism and growth. *Nature Reviews Molecular Cell Biology*, 22(4), 233-247. 8. Park, S. Y., & Kim, J. H. (2019). AKT signaling in cancer: A potential therapeutic target. *Clinical Cancer Research*, 25(12), 3675-3683. 9. Yang, J., & Zhang, L. (2020). The interplay between AKT and mTOR signaling pathways in cancer. *Oncogene*, 39(12), 2530-2540. 10. Zhao, Y., & Wang, Y. (2021). Targeting AKT in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 97, 102195. <a href="AKT Phospho S473 Dylight 549 Conjugated Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=AKT Phospho S473 Dylight 549 Conjugated Antibody</a> <br><strong>Products Related to AKT Phospho S473 Dylight 549 Conjugated Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>